Elite Pharmaceuticals Inc
ELTP- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001053369
In the last 90 days, Elite Pharmaceuticals Inc insiders filed 1 open-market purchase and 0 sales; 1 institution reported holding it in 13F filings for Q2 2026, worth $365 in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Elite Pharmaceuticals Inc changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 1 | 1 | 0 |
| Shares | 500 | 1.00K | +500 (+100.0%) |
| Value | $180 | $365 | +$185 (+102.8%) |
New holders (0)
Institutions that held Elite Pharmaceuticals Inc at the end of Q2 2026 but not at the end of Q1 2026.
None.
Sold out (0)
Institutions that held Elite Pharmaceuticals Inc at the end of Q1 2026 and filed for Q2 2026 without it.
None.